X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2644) 2644
nasopharyngeal carcinoma (1819) 1819
nasopharyngeal neoplasms - virology (1212) 1212
female (1165) 1165
male (1132) 1132
oncology (1132) 1132
cancer (989) 989
middle aged (976) 976
adult (874) 874
carcinoma (803) 803
herpesvirus 4, human - genetics (803) 803
nasopharyngeal neoplasms - pathology (788) 788
epstein-barr virus (763) 763
aged (669) 669
expression (511) 511
herpesvirus 4, human - isolation & purification (483) 483
nasopharyngeal neoplasms - genetics (482) 482
epstein-barr-virus (481) 481
animals (432) 432
cell line, tumor (416) 416
tumors (374) 374
nasopharyngeal neoplasms - metabolism (371) 371
research article (362) 362
prognosis (355) 355
epstein-barr virus infections - virology (346) 346
carcinoma - virology (341) 341
medicine (330) 330
polymerase chain reaction (326) 326
dna (322) 322
metastasis (320) 320
adolescent (318) 318
virology (317) 317
proteins (302) 302
gene expression (301) 301
research (298) 298
herpesvirus 4, human - immunology (296) 296
pathology (296) 296
mice (279) 279
multidisciplinary sciences (275) 275
genetic aspects (274) 274
health aspects (273) 273
apoptosis (269) 269
epstein-barr virus infections - complications (269) 269
science (265) 265
ebv (256) 256
nasopharyngeal neoplasms - diagnosis (247) 247
immunohistochemistry (246) 246
nasopharyngeal neoplasms - immunology (246) 246
radiotherapy (244) 244
viral matrix proteins - genetics (241) 241
chemotherapy (239) 239
analysis (233) 233
stomatognathic diseases (233) 233
infection (228) 228
nasopharyngeal cancer (227) 227
in situ hybridization (226) 226
risk factors (226) 226
cells (224) 224
otorhinolaryngologic diseases (224) 224
viruses (218) 218
gene expression regulation, neoplastic (216) 216
cell biology (215) 215
young adult (212) 212
survival (211) 211
herpesvirus 4, human - physiology (210) 210
patients (210) 210
aged, 80 and over (209) 209
radiation therapy (208) 208
care and treatment (205) 205
carcinoma - pathology (203) 203
nasopharyngeal neoplasms - therapy (200) 200
diagnosis (197) 197
cancer therapies (186) 186
neoplasm staging (185) 185
base sequence (183) 183
medical prognosis (177) 177
signal transduction (175) 175
retrospective studies (174) 174
biochemistry & molecular biology (172) 172
molecular sequence data (171) 171
deoxyribonucleic acid--dna (169) 169
dna, viral - blood (169) 169
gene (169) 169
nasopharyngeal neoplasms - epidemiology (168) 168
viral matrix proteins - metabolism (167) 167
carcinoma, squamous cell - virology (166) 166
nasopharyngeal neoplasms - radiotherapy (166) 166
epstein–barr virus (164) 164
nasopharyngeal neoplasms - drug therapy (163) 163
hemic and lymphatic diseases (162) 162
metastases (162) 162
studies (161) 161
child (160) 160
medical research (158) 158
genes (157) 157
medicine, research & experimental (157) 157
dna, viral - analysis (156) 156
otorhinolaryngology (156) 156
tumor cells, cultured (154) 154
development and progression (151) 151
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2667) 2667
Chinese (109) 109
French (16) 16
Japanese (12) 12
German (6) 6
Russian (4) 4
Spanish (4) 4
Serbian (3) 3
Italian (2) 2
Croatian (1) 1
Danish (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 2017, Volume 123, Issue 9, pp. 1566 - 1575
BACKGROUND Human papillomavirus (HPV) is a well‐established prognostic marker for oropharyngeal squamous cell cancer (OPSCC). Because of the limited numbers of... 
human papillomavirus (HPV) | head and neck squamous cell cancer (HNSCC) | p16 | race | sex | oropharyngeal squamous cell cancer (OPSCC) | prognosis | UNITED-STATES | POSITIVE HEAD | IN-SITU HYBRIDIZATION | IMPROVED SURVIVAL | TRIAL | NASOPHARYNGEAL CARCINOMA | HPV STATUS | THERAPY | ONCOLOGY | IMMUNOHISTOCHEMISTRY | Oropharyngeal Neoplasms - ethnology | Head and Neck Neoplasms - virology | Nasopharyngeal Neoplasms - mortality | Prognosis | Asian Americans - statistics & numerical data | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Nasopharyngeal Neoplasms - ethnology | Nasopharyngeal Neoplasms - virology | Oropharyngeal Neoplasms - mortality | Hispanic Americans - statistics & numerical data | Male | Oropharyngeal Neoplasms - pathology | Carcinoma, Squamous Cell - ethnology | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Mouth Neoplasms - ethnology | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Head and Neck Neoplasms - ethnology | Laryngeal Neoplasms - ethnology | Female | Papillomavirus Infections - virology | Retrospective Studies | Repressor Proteins - metabolism | Oncogene Proteins, Viral - metabolism | Ethnic Groups - statistics & numerical data | Papillomavirus Infections - epidemiology | Proportional Hazards Models | European Continental Ancestry Group - statistics & numerical data | Oropharyngeal Neoplasms - virology | Mouth Neoplasms - virology | Mouth Neoplasms - mortality | Human papillomavirus 16 - metabolism | Head and Neck Neoplasms - pathology | African Americans - statistics & numerical data | Papillomavirus E7 Proteins - metabolism | Laryngeal Neoplasms - mortality | Sex Factors | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Mouth Neoplasms - pathology | Head and Neck Neoplasms - mortality | Neoplasm Staging | DNA, Viral | Human papillomavirus 16 - genetics | Laryngeal Neoplasms - virology | Complications and side effects | Care and treatment | DNA | Head and neck cancer | Research | Papillomavirus infections | Risk factors | Sex | Risk | Population studies | mRNA | Nasopharynx | Human papillomavirus | Race | Larynx | Deoxyribonucleic acid--DNA | Squamous cell carcinoma | Head | Adjustment | Mortality | Health risks | Hazards | Ribonucleic acid--RNA | Minority & ethnic groups | Patients | Survival | Oral cavity | Tobacco | Medical prognosis | Men | Health hazards | Health risk assessment | Hispanics | Cancer | Tumors
Journal Article
Oral Oncology, ISSN 1368-8375, 2013, Volume 49, Issue 1, pp. 79 - 85
Summary Objectives To describe the natural course of distant metastases (DMs) following radiotherapy (RT) or chemoradiotherapy (CRT) in HPV(+) oropharyngeal... 
Otolaryngology | Hematology, Oncology and Palliative Medicine | Distant metastasis | Human papillomavirus | Oropharyngeal carcinoma | Radiotherapy | Chemoradiotherapy | SURVIVAL | HEAD | HUMAN-PAPILLOMAVIRUS | P16(INK4A) | SUBSET | PHASE-III TRIAL | NASOPHARYNGEAL CARCINOMA | ONCOLOGY | DENTISTRY, ORAL SURGERY & MEDICINE | SQUAMOUS-CELL CARCINOMA | EPSTEIN-BARR-VIRUS | NECK-CARCINOMA | Oropharyngeal Neoplasms - therapy | Papillomavirus Infections - radiotherapy | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Carcinoma - virology | Salvage Therapy | Male | Papillomavirus Infections - therapy | Neoplasm Recurrence, Local - pathology | Lung Neoplasms - secondary | Tongue Neoplasms - virology | Aged, 80 and over | Adult | Female | Retrospective Studies | Tonsillar Neoplasms - therapy | Liver Neoplasms - secondary | Carcinoma - secondary | Tongue Neoplasms - radiotherapy | Liver Neoplasms - virology | Radiotherapy Dosage | Tongue Neoplasms - therapy | Alphapapillomavirus - classification | Oropharyngeal Neoplasms - radiotherapy | Survival Rate | Oropharyngeal Neoplasms - virology | Carcinoma - radiotherapy | Lung Neoplasms - virology | Tonsillar Neoplasms - radiotherapy | Tonsillar Neoplasms - virology | Skin Neoplasms - virology | Skin Neoplasms - secondary | Carcinoma - therapy | Aged | Neoplasm Staging | Cohort Studies | Care and treatment | Metastasis | Nuclear radiation | Papillomavirus infections | Cancer
Journal Article
British Journal of Hospital Medicine, ISSN 1750-8460, 10/2016, Volume 77, Issue 10, pp. 565 - 568
Virus infections are an important factor in the global burden of human cancer. The discovery and mode of action of human tumour viruses is briefly reviewed... 
IMMUNE-RESPONSE | MEDICINE, GENERAL & INTERNAL | SEQUENCES | VACCINATION | PREVENTION | HUMAN-PAPILLOMAVIRUS | CANCER | CARCINOMA | EPSTEIN-BARR-VIRUS | MERKEL CELL POLYOMAVIRUS | INSIGHTS | Viral Vaccines - therapeutic use | Leiomyosarcoma - virology | Carcinoma, Hepatocellular - prevention & control | Humans | Carcinoma - virology | Nasopharyngeal Neoplasms - virology | Male | Neoplasms - prevention & control | Epstein-Barr Virus Infections - prevention & control | Neoplasms - virology | Skin Neoplasms - prevention & control | Female | Hepatitis B virus | Liver Neoplasms - prevention & control | Liver Neoplasms - virology | Oncogenic Viruses | Stomach Neoplasms - virology | Uterine Cervical Neoplasms - prevention & control | Vulvar Neoplasms - virology | Carcinoma - prevention & control | Carcinoma, Hepatocellular - virology | Tumor Virus Infections - prevention & control | Adenocarcinoma - virology | Herpesvirus 4, Human | Adenocarcinoma - prevention & control | Papillomavirus Infections - prevention & control | Lymphoma - prevention & control | Skin Neoplasms - virology | Stomach Neoplasms - prevention & control | Vulvar Neoplasms - prevention & control | Uterine Cervical Neoplasms - virology | Papillomaviridae | Nasopharyngeal Neoplasms - prevention & control | Leiomyosarcoma - prevention & control | Hepacivirus | Epidermodysplasia Verruciformis - prevention & control | Lymphoma - virology
Journal Article
Cancer, ISSN 0008-543X, 2017, Volume 123, Issue 14, pp. 2642 - 2650
BACKGROUND Early‐stage and intermediate‐stage nasopharyngeal cancer (NPC) generally carry a good prognosis, but for patients with recurrent, metastatic... 
adoptive T‐cell immunotherapy | nasopharyngeal carcinoma | clinical trials | phase 1/2 | Epstein‐Barr virus | adoptive T-cell immunotherapy | Epstein-Barr virus | CARBOPLATIN | MANAGEMENT | COMBINATION | CHEMOTHERAPY | GEMCITABINE | PACLITAXEL | PATHOGENESIS | CYTOTOXIC T-CELLS | PHASE-II TRIAL | ONCOLOGY | LYMPHOCYTES | Bone Neoplasms - therapy | Humans | Middle Aged | Carcinoma - virology | Nasopharyngeal Neoplasms - virology | Neoplasm Recurrence, Local - virology | Bone Neoplasms - secondary | Male | Liver Neoplasms - therapy | Nasopharyngeal Neoplasms - secondary | Feasibility Studies | Nasopharyngeal Neoplasms - pathology | Young Adult | Neoplasm Metastasis | Flow Cytometry | Lung Neoplasms - secondary | T-Lymphocytes, Cytotoxic - transplantation | Adult | Female | Carcinoma - pathology | Liver Neoplasms - secondary | Carcinoma - secondary | T-Lymphocytes, Cytotoxic - immunology | Immunotherapy, Adoptive - methods | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms - therapy | Neoplasm Recurrence, Local - therapy | Herpesvirus 4, Human - immunology | Enzyme-Linked Immunospot Assay | Lung Neoplasms - therapy | Disease Progression | Disease-Free Survival | Pilot Projects | Carcinoma - therapy | Aged | Chemotherapy | Usage | Care and treatment | Immunotherapy | Research | Nasopharyngeal cancer | Cancer | Antigens | Prognosis | Effectiveness | Adoptive immunotherapy | Cytotoxicity | Viruses | Lymphocytes T | Metastasis | Disease control | Patients | Survival | Metastases | Nasopharyngeal carcinoma | Antigen (tumor-associated) | Medical prognosis | Remission | Informed consent | Manufacturing
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 5, pp. 1845 - 1850
Purpose To report the mature data of a prospective Phase II trial designed to evaluate the efficacy of an epidermal growth factor receptor inhibitor cetuximab... 
Radiology | Hematology, Oncology and Palliative Medicine | Concurrent cetuximab | Chemoradiation | Locally advanced head and neck cancer | Concurrent chemotherapy | SURVIVAL | RANDOMIZED-TRIAL | HUMAN-PAPILLOMAVIRUS | CANCER | STAGE OROPHARYNX CARCINOMA | CHEMOTHERAPY | RADIATION-THERAPY | GROWTH-FACTOR RECEPTOR | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Oropharyngeal Neoplasms - therapy | Chemoradiotherapy - adverse effects | Head and Neck Neoplasms - virology | Nasopharyngeal Neoplasms - mortality | Prospective Studies | Follow-Up Studies | Area Under Curve | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Oropharyngeal Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Oropharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - mortality | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Carboplatin - adverse effects | Antibodies, Monoclonal, Humanized | Laryngeal Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Adult | Female | Cetuximab | Paclitaxel - administration & dosage | Chemoradiotherapy - methods | ErbB Receptors - antagonists & inhibitors | Drug Administration Schedule | Nasopharyngeal Neoplasms - therapy | Head and Neck Neoplasms - therapy | Carboplatin - administration & dosage | Carcinoma, Squamous Cell - therapy | Paclitaxel - adverse effects | Oropharyngeal Neoplasms - virology | Papillomaviridae - isolation & purification | Remission Induction | Head and Neck Neoplasms - pathology | Hypopharyngeal Neoplasms - therapy | Laryngeal Neoplasms - mortality | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hypopharyngeal Neoplasms - pathology | Aged | Head and Neck Neoplasms - mortality | Neoplasm Staging | Medical colleges | Care and treatment | Squamous cell carcinoma | Radiation | Clinical trials | Radiotherapy | Antineoplastic agents | Antimitotic agents | Epidermal growth factor | Nuclear radiation | Analysis | Paclitaxel | Cancer | Index Medicus | GROWTH FACTORS | HEAD | PATIENTS | DERMATITIS | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | TOXICITY | NECK | RADIOTHERAPY | RECEPTORS
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 6, pp. 10238 - 10254
The Epstein-Barr virus (EBV) is etiologically associated with the development of multiple types of tumors, but it is unclear whether this diversity is due to... 
Epstein-Barr virus strains | Carcinoma and lymphoma | Host-virus interactions | Human tumor viruses | Viral infection and transformation | LYTIC INFECTION | PROTEIN | SHOWS | SUSCEPTIBILITY | human tumor viruses | carcinoma and lymphoma | CELL BIOLOGY | B-CELLS | host-virus interactions | NASOPHARYNGEAL CARCINOMA | TROPISM | EPITHELIAL-CELLS | viral infection and transformation | GASTRIC-CARCINOMA CELLS | EBV | Nasopharyngeal Neoplasms - genetics | Nasopharyngeal Neoplasms - metabolism | Cell Proliferation | Epithelial Cells - metabolism | Herpesvirus 4, Human - genetics | Coculture Techniques | Humans | Carcinoma - virology | Nasopharyngeal Neoplasms - virology | Stomach Neoplasms - metabolism | MicroRNAs - metabolism | Stomach Neoplasms - pathology | Viral Proteins - metabolism | Virus Internalization | Nasopharyngeal Neoplasms - pathology | Herpesvirus 4, Human - isolation & purification | RNA, Viral - genetics | Time Factors | HEK293 Cells | B-Lymphocytes - virology | Epstein-Barr Virus Infections - genetics | Herpesvirus 4, Human - pathogenicity | RNA, Viral - metabolism | B-Lymphocytes - pathology | Viral Tropism | Carcinoma - pathology | B-Lymphocytes - metabolism | Caco-2 Cells | Stomach Neoplasms - genetics | Nasopharyngeal Carcinoma | Epstein-Barr Virus Infections - virology | Stomach Neoplasms - virology | Viral Proteins - genetics | Epithelial Cells - pathology | Mice, SCID | Epstein-Barr Virus Infections - pathology | Host-Pathogen Interactions | Animals | Virus Replication | Epithelial Cells - virology | Carcinoma - genetics | MicroRNAs - genetics | Carcinoma - metabolism | Herpesvirus 4, Human - classification | Epstein-Barr Virus Infections - metabolism | Cell Transformation, Viral
Journal Article
Nature reviews. Cancer, ISSN 1474-1768, 2004, Volume 4, Issue 10, pp. 757 - 768
Journal Article
JAMA otolaryngology-- head & neck surgery, ISSN 2168-6181, 12/2013, Volume 139, Issue 12, pp. 1320 - 1327
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2017, Volume 98, Issue 5, pp. 996 - 1001
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 2015, Volume 108, Issue 1, p. djv291
Journal Article
Cancer, ISSN 0008-543X, 05/2017, Volume 123, Issue 10, pp. 1778 - 1790
BACKGROUND The incidence of human papillomavirus (HPV)‐associated (HPV‐positive) head and neck squamous cell